Long-form notes on
a misunderstood plant.

A label that says “strong” tells you nothing. A label that says 100 mg total THC across 10 servings tells you that a serving is 10 mg — a meaningful adult dose and roughly double what a first-time user should take. The same package described as “premium” and “full spectrum” could be 40 mg or 400 mg. The number is the only part that transfers between products.

Look for the serving count before the milligram count. A chocolate bar at 100 mg is not the same product as a chocolate bar at 100 mg cut into twenty squares rather than ten. Dose per piece is what your evening actually depends on.

Then look for the batch number. A batch number is a promise that someone can trace this specific unit back to a specific extraction, which in turn maps to a specific test result. If a producer cannot tell you the cannabinoid content of the batch in your hand, the number printed on the front is marketing rather than measurement.

Finally, read the ingredient list for the carrier. Edibles are infused into fat or sugar, and the carrier changes both the onset and the duration. Honey and chocolate run longer than a gummy because they are digested more slowly. That is not a quality difference — it is a scheduling difference, and it is worth planning around.

Swallowed THC passes through the liver before it reaches the brain. There, an enzyme called CYP2C9 converts a portion of it into 11-hydroxy-THC, a metabolite that crosses the blood-brain barrier more readily and produces a longer, heavier effect. The edible experience is largely the experience of this metabolite.

How efficiently you make that conversion depends on genetics, on liver enzyme activity, and on what else you have eaten. A fatty meal slows gastric emptying, which delays onset and can make the peak sharper when it finally arrives. Alcohol competes for the same enzymes. Even a course of antibiotics can shift the picture.

This is why the two-hour rule exists, and why it is not a suggestion. If you take a second dose at forty-five minutes because “nothing is happening”, you are stacking a dose on top of one that has not yet been converted. When both arrive, they arrive together.

The practical response is boring and effective: same product, same dose, same time of day, on an empty-ish stomach, for three sessions. You are not looking for a thrill — you are looking for a baseline you can trust.

Terpenes are the volatile compounds responsible for the smell of the plant — myrcene, limonene, pinene, linalool. They are present in meaningful concentrations, they vary between cultivars, and they demonstrably shape the sensory experience of inhaling or tasting a product.

The stronger claim, that specific terpenes reliably produce specific effects through an “entourage effect”, is where the evidence thins out. The entourage concept is plausible and actively researched, but most of what is sold as terpene-based guidance is extrapolation from preclinical work at concentrations that a smoked flower does not deliver.

What this means for buying is straightforward. Treat terpene descriptions as flavour notes, not as pharmacology. “Limonene-forward” tells you what it smells like. It does not tell you whether the product will make you anxious or sleepy.

The most reliable predictors of an experience remain dose, ratio and format — in that order. Aromatics are the pleasure of the thing, not the mechanics of it.

CBN is what THC becomes as it oxidises — leave a flower in the light long enough and the profile shifts. It binds CB1 receptors weakly compared with THC, and early research suggested sedating properties. That research was largely in animal models, and the human evidence is thin.

The sedating reputation is probably amplified by two things: the THC that is usually present alongside it, and the fact that people reach for these products at bedtime, which makes the attribution obvious and the causality unclear.

At Land O Smiles we use CBN at a 1:1 ratio with THC in our night formula, rather than as a standalone. The reasoning is honest: we can measure the combination, and the combined effect is noticeable. We do not sell a CBN-only product, because we cannot yet point to evidence that would justify the price.

If sleep is the goal, treat any cannabis product as a short-term aid rather than a treatment for insomnia. Persistent sleep problems have causes that a tincture will not fix, and a clinician is the right person to look for them.

Cannabis has been cultivated in the Great Lakes region for a very long time, and its history here is not a story that begins with prohibition. It travelled along trade routes, was grown in household plots, and was used in ways that had nothing to do with the dispensary culture that dominates the global conversation today.

Colonial administration criminalised it, and post-independence legislation largely inherited that framework. Uganda’s Narcotic Drugs and Psychotropic Substances (Control) Act remains restrictive, and the licensing environment for medical and industrial cannabis has moved more slowly than the commercial interest around it.

We operate in that gap carefully. We publish what we test, we sell only to adults, we do not make medical claims, and we do not pretend the legal picture is settled. If you are buying from us, you are responsible for knowing the rules where you live.

The commercial future of this plant in Uganda is likely to be medical and industrial rather than recreational. That is a reasonable outcome for a country with the agricultural capacity and climate to supply it — provided the regulation that arrives is evidence-based rather than inherited by default.